Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BC003 versus nitroglycerin in acute decompensated heart failure
CTR20250722Phase 3Completed
- Sponsor
- Shandong Danhong Pharmaceutical
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of nesiritide in heart failure (HF), sponsored by Shandong Danhong Pharmaceutical. Started May 2025; status: completed.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on CTR20250722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250722.